ARCpoint Inc
0.01
CAD
+0.00
(-50.00%)
ISIN
CA03966D1078
CUSIP
03966D107
Return %
Stock
S&P 500
1Y
-91.67
14.20
3Y
-98.15
81.12
5Y
- -
68.34
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Quarterly Revenue
USD
•
in mil. unless spec.Quarterly Earnings Per Share
USD
•
in mil. unless spec.Quarterly Dividends Per Share
USD
•
in mil. unless spec.Company Description
- CEO
- Peter Kendall
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Greenville United States
- IPO Date
- Sep 18, 1998
- Website
- arcpointlabs.com
- Similar Companies
- Business
- ARCpoint Inc. operates as a healthcare technology and diagnostic testing company providing a comprehensive suite of clinical laboratory testing, toxicology screening, and occupational compliance solutions across North America. Founded in 1998 and headquartered in Greenville, South Carolina, the company operates primarily through its nationwide ARCpoint Labs franchise system, corporate-owned testing facilities, and proprietary digital health platforms. ARCpoint serves a diverse client base comprising enterprise employers, individual consumers, judicial agencies, legal professionals, insurance providers, and healthcare practitioners across three primary business segments: Franchise Operations, Corporate Locations, and Digital Health Solutions. The company offers an extensive portfolio of testing and healthcare compliance services, which includes drug, alcohol, and toxicology screening, encompassing Department of Transportation (DOT) and non-DOT workplace testing, urine drug screenings, hair follicle testing, oral fluid analysis, breath alcohol testing, fingernail toxicology, and automated random drug pool management; clinical laboratory and wellness diagnostics, encompassing comprehensive metabolic profiles, lipid panels, complete blood count (CBC) assays, thyroid testing, hormone evaluations, allergy and food sensitivity testing, infectious disease screening, and sexually transmitted infection (STI) diagnostics; DNA and molecular testing services, encompassing legal and non-legal paternity testing, relationship verification, immigration DNA testing, ancestry profiling, and pharmacogenomic screening; occupational health and employment screening services, encompassing pre-employment criminal background checks, motor vehicle record verifications, employment and education credential verifications, I-9 compliance management, pre-placement physical examinations, pulmonary function testing, respiratory fit testing, and tuberculosis screenings; and digital health and telehealth services, encompassing direct-to-consumer physician-ordered diagnostic requisitions, virtual medical consultations, electronic results delivery, and automated compliance tracking delivered through the proprietary ARCpoint Connect and MyARCpoint digital platforms. In recent developments, ARCpoint has advanced its strategic transformation into a technology-enabled healthcare and diagnostic access network through the continued expansion and commercialization of its ARCpoint Connect platform, enabling consumers and enterprise clients to seamlessly order diagnostic tests, access telehealth consultations, and manage digital health records online. The company has deepened its strategic laboratory network integrations with major national reference laboratories, including Labcorp and Quest Diagnostics, extending its nationwide fulfillment reach and specimen collection infrastructure. Additionally, ARCpoint continues to expand its geographic footprint by awarding new franchise territories across the United States, scaling mobile and on-site testing unit deployments for corporate and industrial employers, and broadening its B2B occupational health software integrations to provide real-time compliance reporting and workforce safety management.